# A Silent Obstruction: Ureteropelvic Junction Syndrome Presenting As Resistant Hypertension in an Adult

**Authors:** Miguel Martins, Valter Duarte, Daniela R Alves, Gisela Gonçalves, Ana Rita Barbosa

PMC · DOI: 10.7759/cureus.101746 · 2026-01-17

## TL;DR

A rare kidney blockage caused long-term high blood pressure in an adult, showing the need for thorough imaging and targeted treatment.

## Contribution

Identifies ureteropelvic junction obstruction as a rare cause of resistant hypertension in adults.

## Key findings

- Ureteropelvic junction obstruction can lead to chronic hydronephrosis and hypertension.
- Nephrectomy may improve blood pressure control in selected patients.
- Detailed imaging is crucial for diagnosing rare secondary hypertension causes.

## Abstract

Resistant arterial hypertension warrants systematic evaluation for secondary causes, including rare structural anomalies of the urinary tract. Ureteropelvic junction obstruction can lead to chronic hydronephrosis, progressive renal dysfunction, and sustained activation of the renin-angiotensin-aldosterone system.

We present the case of a 50-year-old woman with resistant hypertension referred for secondary cause evaluation. The patient reported paroxysmal facial flushing, headaches, palpitations, and abdominal distension. Physical examination revealed a large, non-tender mass in the right upper quadrant. Laboratory workup and target organ assessment were unremarkable. Contrast-enhanced abdominal CT demonstrated severe hydronephrosis with ureteropelvic junction obstruction, marked renal parenchymal atrophy, and ipsilateral vascular anomalies with accessory renal arteries and a partially thrombosed aneurysm. Renal scintigraphy confirmed non-function of the affected kidney, and nephrectomy was proposed.

This case highlights ureteropelvic junction obstruction as a rare but clinically significant cause of secondary hypertension in adults. It emphasizes the importance of detailed imaging in evaluating resistant hypertension and the role of targeted interventions, such as nephrectomy, in selected patients, with potential improvement in blood pressure control and cardiovascular outcomes.

## Linked entities

- **Diseases:** hydronephrosis (MONDO:0005510)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** palpitations (MESH:D006331), abdominal distension (MESH:D000007), functional impairment of the right kidney (MESH:D007674), obstructive sleep apnea (MESH:D020181), Structural abnormalities of the urinary tract (MESH:D014570), vascular anomalies (MESH:D020785), AHT (MESH:D000081029), renovascular hypertension (MESH:D006978), Hypertension (MESH:D006973), flushing (MESH:D005483), hydronephrosis (MESH:D006869), weight loss (MESH:D015431), endocrinopathies (MESH:C567425), aneurysmal dilation (MESH:D002311), accessory renal arteries (MESH:D012078), hypertensive retinopathy (MESH:D058437), UPJS (MESH:C537373), chest pain (MESH:D002637), Chronic obstruction (MESH:D029424), nausea (MESH:D009325), essential hypertension (MESH:D000075222), cutaneous abnormalities (MESH:D018366), cervical masses (MESH:D002575), damage (MESH:D020263), chronic renal ischemia (MESH:D007511), syncope (MESH:D013575), anomalies of (MESH:D000013), headaches (MESH:D006261), atrophy (MESH:D001284), edema (MESH:D004487), vascular abnormalities (MESH:D014652), aneurysm (MESH:D000783)
- **Chemicals:** creatinine (MESH:D003404), indapamide (MESH:D007190), perindopril (MESH:D020913), lercanidipine (MESH:C060343), aldosterone (MESH:D000450)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909289/full.md

---
Source: https://tomesphere.com/paper/PMC12909289